The bone marrow constitutes a reservoir of pericyte progenitors
|
|
- Maximilian Gilmore
- 6 years ago
- Views:
Transcription
1 Uncorrected Version. Published on August 3, 2006 as DOI: /jlb The bone marrow constitutes a reservoir of pericyte progenitors Chrystelle Lamagna and Gabriele Bergers 1 Department of Neurological Surgery, Brain Tumor Research Center and UCSF Comprehensive Cancer Center, University of California San Francisco Abstract: Adult bone marrow is a rich reservoir of hematopoietic and mesenchymal stem and progenitor cells. Mobilization and recruitment of bone marrow-derived cells to injured or ischemic tissue or tumors endorse the initiation and maintenance of angiogenic processes in the adult by incorporating endothelial progenitor cells (EPC) into the developing vasculature and by recruiting accessory hematopoietic cells. Recent data have now revealed that the origin of bone marrow-derived vascular cells is not restricted to endothelial cells but also includes pericytes the perivascular support cells. Several laboratories have now reported the existence of pericyte progenitor cells, and these cells, like EPC, can be mobilized and recruited to the remodeling vasculature under ischemic conditions and in tumors. This review focuses on pericytes in vessel formation and on recent discoveries about their bone marrow origin in the adult. J. Leukoc. Biol. 80: ; Key Words: tumor PDGFR- INTERACTION OF ENDOTHELIAL CELLS AND PERICYTES IN BLOOD VESSEL FORMATION Blood vessels consist of endothelial cells, which form the inner lining of blood vessels and pericytes, also referred to as vascular smooth muscle cells or mural cells, and are embedded within the vascular basement membrane and envelop the surface of the vascular tube. When blood vessels develop in the embryo, mesodermal precursors (angioblasts) or hematopoietic precursors (hemangioblasts) first assemble into a primitive, vascular plexus in a process termed vasculogenesis [1]. This primitive endothelial network then undergoes extensive remodeling, referred to as angiogenesis, in which endothelial sprouting, intussusception, and pruning extend the network to ensure appropriate vascularization of growing organs. In vessel sprouting, endothelial cells invade the surrounding extracellular matrix and form a column of migrating and proliferating endothelial cells. These sprouts then cease proliferation and form a new lumen-containing vessel. Next, vessels become enveloped by pericytes, when activated endothelial cells secrete plateletderived growth factor (PDGF)-B, which signals through its receptor PDGFR-, expressed by pericytes, resulting in proliferation and recruitment of pericytes to the newly formed vessels [2, 3]. Pericytes promote vascular maturation and terminate the remodeling process. As a result of their contractile capabilities and their multiple cytoplasmic processes, pericytes have mainly been associated with stabilization and hemodynamic processes of blood vessels. They express myofilaments such as -smooth muscle actin ( -SMA) or desmin and also PDGFR-, NG2-proteoglycan/HMW-MMA, and the regulator G-protein signaling RGS5. These markers, however, are not solely pericyte-specific, and their expression is stage- and tissue-specific [4, 5]. In contrast to endothelial cells, pericytes have a more complex ontogeny, as they can develop from various cells, as a function of their location in the embryo. They can arise from the neurocrest [6] to develop into the CNS or from the cardiac tract to envelop coronary vessels [7]. Most commonly, however, pericytes appear to develop from mesenchymal stem cells [8]. It also has been reported that embryonic endothelial cells can transdifferentiate into perivascular cells, although this process appears to be rather rare in normal development [9]. In addition, Flk1 cells derived from mesodermal tissue can differentiate into endothelial cells or pericytes upon stimulation by vascular endothelial growth factor (VEGF) or PDGF-B, respectively, and organize into vessel-like structures in vitro. This suggests that endothelial cells and pericytes share a common progenitor cell during the development the Flk1 angioblast [10]. As soon as homogenous vessels are formed, they undergo arteriovenous differentiation and regional specialization to support the specific needs of the different tissues that they supply. For example, endothelial cells in the brain form a continuous endothelium with tight barriers to prevent the entry of neurotoxic blood-derived factors, whereas in the kidney glomerulus, capillaries are highly permeable to facilitate the exchange of salts and metabolites [11]. Similarly, the dense population of pericytes in the brain, with their elongated and multiple cytoplasmic processes that wrap around the capillaries, is essential to maintaining the blood-brain barrier, whereas pericytes of the glomerular capillaries in the kidney are more compact and rounded, making minimal focal contacts with vessels to ensure sufficient blood ultrafiltration [4, 5]. In summary, endothelial cells and pericytes regulate vessel formation, maturation, and specification, all of which requires the orchestration of tightly regulated molecules. They communicate with each other by direct cell contact and by paracrine signaling pathways. It is therefore conceivable that pericytes 1 Correspondence: University of California San Francisco, Department of Neurological Surgery, 513 Parnassus Avenue, San Francisco, CA gabriele.bergers@ucsf.edu Received May 8, 2006; revised June 26, 2006; accepted June 27, 2006; doi: /jlb /06/ Society for Leukocyte Biology Journal of Leukocyte Biology Volume 80, October Copyright 2006 by The Society for Leukocyte Biology.
2 and endothelial cells are interdependent and that defects in either can affect the vascular system. For example, defects in PDGF-B/PDGFR- signaling affect pericytes and endothelial cells, leading to an abnormal vasculature. During angiogenesis in the embryo and in the adult, PDGF-B is expressed by the sprouting endothelial cells, whereas its receptor, PDGFR-, is localized on pericytes, indicating a paracrine signaling circuit between the two cell types [12, 13]. Indeed, genetic deletions of PDGF-B or PDGFR- in mice produce identical phenotypes. Mice deficient in PDGF-B or PDGFR-, both die during late gestation from cardiovascular complications, which endorse widespread microvascular leakage and edema. Blood vessel dilation and microaneurysms in mutant mice correlate with a severe reduction or even a total loss of pericytes on the affected vessels [12, 14 16]. Furthermore, mice bearing specific mutations in the Src homology 2, binding phosphorylated tyrosines of PDGFR-, and thus, harboring an impaired PDGFR- signaling pathway have been shown to exhibit a reduction in pericytes in various tissues, such as brain, heart, and retina [17, 18]. It is interesting that deficiency in the PDGF-B/PDGFR- pathway also affects the functionality of tumor vessels, which are poorly organized, appear tortuous and irregularly shaped, and are often unable to support efficient blood flow [19, 20]. This can be explained by the fact that tumors appear to be in a constant active state of vascular remodeling as a result of the imbalanced expression pattern of angiogenic factors, which involves simultaneous formation and regression of vascular tubes [2]. This phenotype is seen in endothelial cells and pericytes found in tumors. In general, pericytes are less abundant in tumors than in respective normal tissues; they often are more loosely attached to the vascular tubes, and their cytoplasmic processes can extend into the interstitial tumor tissues [4, 21]. For all of these reasons, pericytes were thought to be rather abnormal and dysfunctional in tumors, but recent data from several laboratories point to the opposite conclusion: Tumor pericytes are still functional and important for vessel stability and survival. For example, the administration of a neutralizing antibody against PDGFR- or pharmacological inhibition of PDGFR- signaling in a transgenic mouse model of pancreatic tumorigenesis (rat insulin promoter 1 T-antigen 2) leads to the dissociation and depletion of tumor pericytes but not of normal quiescent pericytes and consequently, to enlarged and hyperdilated tumor vessels [22 25]. It is most important that pericyte depletion induced high levels of apoptotic endothelial cells in tumors, as pericytes provide essential survival factors for endothelial cells, such as VEGF [22]. In agreement, immature blood vessels without pericytes were much more vulnerable to anti-vegf therapy [26], and combinatorial inhibition of PDGFR and VEGFR signaling to target pericytes and endothelial cells in tumors had synergistic efficacy in late-stage disease, disrupting the established tumor vasculature and affecting tumor regression [25, 27]. These data further strengthen the knowledge that tumor pericytes function in protecting endothelial cells, partly by expressing the survival factor VEGF [22]. Recent data demonstrated that dysfunctions in pericyte-endothelial communication can even lead to metastatic spread of tumor cells, further supporting the notion that endothelial-pericyte interactions are critical to maintaining a healthy vasculature [28]. THE BONE MARROW CONNECTION Historically, the formation of new vessels has been associated with activation of existing endothelial cells within the injured tissue or tumor. However, several reports describe that angiogenesis in the adult is also supported by the mobilization and functional incorporation of bone marrow-derived circulating endothelial progenitor cells and by the recruitment of accessory hematopoietic cells [29 31]. The percentage of endothelial progenitor cells and other bone marrow-derived cells, which are recruited to the tumor vasculature, can vary dramatically between tumor types and sometimes even between different stages of one tumor type [32, 33]. Therefore, the functional significance of adult vasculogenesis remains an area of intense debate but also of high interest. At least two major pathways have been described for the attraction of bone marrow-derived cells. In the first pathway, chemokines such as VEGF and PDGF, which are released by the tumor or injured tissue, induce and activate matrix metalloproteinase-9 in the bone marrow to release soluble Kit ligand, thereby promoting stem cell cycling and motility [34, 35]. In the second pathway, CXCR4 ligand stromal-derived factor 1 [(SDF-1)/CXCL12], which can be induced by hypoxia and VEGF and is expressed by myofibroblasts or endothelial cells, is involved in the recruitment of CXCR4 hematopoietic progenitors to ischemic tissues and tumors. It has been proposed that SDF-1 retains CXCR4 bone marrow-derived cells around angiogenic blood vessels [29, 36, 37]. Recently, bone marrow-derived cells, which developed into pericytes, were identified, enveloping the growing vasculature in tumors and injured tissues. One of the first studies, which proposed the existence of bone marrow-derived pericyte progenitors, showed that CD11b and CD45 hematopoietic cells, expressing the pericyte marker NG2, are detected in close proximity to blood vessels in a subcutaneous Bl6-F1 melanoma model [38]. The existence of bone marrow-derived pericyte progenitor cells (PPCs) was further substantiated by the identification of PDGFR- pericyte progenitors (PPPs) in an endogenous mouse model of pancreatic tumorigenesis [22]. It is important to note that in these tumors, only perivascular cells express PDGFR-, whereas endothelial cells secrete the ligand PDGF-B, resembling the same situation as during embryonic vessel formation. PPPs in these tumors were able to differentiate into mature pericytes, expressing the markers NG2, -SMA, and desmin, as well as regulate vessel stability and vascular survival of tumors [22]. It is interesting that whereas PDGFR- PPCs induced NG2 and -SMA when cultured alone, coculture of PDGFR- PPCs with endothelial cells was essential to promote development of desmin pericytes. This suggests the necessity of paracrine signaling pathways between endothelial cells and pericytes to enable the induction of desmin. It is intriguing that a subset of PDGFR- PPCs was found to be recruited from the bone marrow to perivascular sites within tumors. These bone marrow-derived cells expressed hematopoietic markers such as 2 Journal of Leukocyte Biology Volume 80, October
3 stem cell antigen-1 (Sca-1) and CD11b, although it is still unclear whether PPPs are of hematopoietic or mesenchymal origin. Bone marrow transplant experiments and cultures of bone marrow-derived or tumor-derived Sca-1 cells with endothelial cells revealed that it is the Sca-1 cell population from the bone marrow that is recruited to angiogenic sites of the tumor and then matures into pericytes [22]. In agreement with these findings, pericyte progenitors also appear to be recruited from the bone marrow in an orthotopic model of neuroblastoma (Fig. 1) [39]. There are several indications that recruitment of pericyte progenitors is not limited to tumors. Bone marrow-derived pericyte progenitors were also found to infiltrate the brain after middle cerebral artery occlusion in an experimental mouse model stroke. PPPs were observed around growing blood vessels in ischemic areas and developed into desmin pericytes, which express TGF- and VEGF [40]. Furthermore, bone marrow-derived cells were observed in angiogenic vessels of the cornea after basic fibroblast growth factor-induced neovascularization and differentiated into NG2 /PDGFR- periendothelial cells [41]. It is interesting that only 50% of the NG2 /PDGFR- PPP population was derived from the bone marrow and expressed the hematopoietic markers CD45 and CD11b. Given that only subsets of PPPs are recruited from the bone marrow [22, 41], it is conceivable that PPPs can also be attracted to angiogenic vessels from the local environment or become activated within the injured tissue or tumor. For example, it has been shown that stroma-derived mesenchymal progenitor cells found in tumors, expressing the markers Sca- 1 /Tie2 /CD13, can differentiate into -SMA pericytes, which then become negative for Tie-2 [30]. It is important to note that there are several reports describing the presence of bone marrow-derived cells that display perivascular localization in tumors but are not pericytes. Among these cells, hematopoietic and monomyolocytic cells probably represent the largest population of bone marrowderived cells [35]. De Palma et al. [42] described a population Fig. 1. Pericyte progenitors are recruited from the bone marrow and the tumor microenvironment. Just as demonstrated for endothelial progenitors, it is likely that tumors secrete cytokines, which induce a cascade of events leading to the mobilization of bone marrow-derived pericyte progenitors to angiogenic sites of tumors or injured tissue (Steps 1 5). At least two populations of bone marrow-derived cells give rise to tumor pericytes (Step 6). The PDGFR- /Sca-1 /CD11b population differentiates into NG2 / -SMA /Desmin mature pericytes [22], whereas the CD45 /CD11b cell population differentiates into pericytes, which only express NG2 [38]. In addition, pericyte progenitors can originate from the local environment. These cells were shown to express the markers Sca-1, Tie2, and CD13 and develop into -SMA cells [30]. Lamagna and Bergers Bone marrow and pericyte progenitors 3
4 of Sca-1 /CD45 /CD11b myeloid tumor-infiltrating cells that express the Tie2 angiopoietin receptor [Tie2-expressing monocytes (TEMs)], which promotes tumor angiogenesis. When coinjected with mammary tumor cells, TEMs increase the number of CD45 infiltrating leukocytes and NG2 pericytes. However, even when TEMs displayed a perivascular location similar to that of pericytes, they did not express the pericyte markers NG2 or -SMA [30]. Similarly, Grunewald et al. [29] described the recruitment of CXCR4 bone marrow-derived cells, which localize in close proximity to blood vessels but do not appear to contribute to the pericyte population. Finally, myofibroblasts, which resemble fibroblasts but share mechanical properties and cytoskeletal proteins such as -SMA with smooth muscle cells, were also reported to partly originate from the bone marrow in tumors [43], but in contrast to pericytes, myofibroblasts display a stromal localization. In summary, there is emerging evidence that bone marrowderived cells play a crucial role in the formation of blood vessels in the adult by incorporating into the growing vasculature, localizing adjacent to it, or enveloping the vasculature to serve as perivascular support cells. ACKNOWLEDGMENTS This work was supported by a grant from the National Institutes of Health (RO1 CA109390) and by a fellowship from the Swiss National Foundation to C. L. We thank Ilona Garner for help with the manuscript preparation. REFERENCES 1. Carmeliet, P. (2004) Manipulating angiogenesis in medicine. J. Intern. Med. 255, Bergers, G., Benjamin, L. E. (2003) Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 3, Gerhardt, H., Betsholtz, C. (2003) Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res. 314, Bergers, G., Song, S. (2005) The role of pericytes in blood-vessel formation and maintenance. Neuro-oncol. 7, von Tell, D., Armulik, A., Betsholtz, C. (2006) Pericytes and vascular stability. Exp. Cell Res. 312, Bergwerff, M., Verberne, M. E., DeRuiter, M. C., Poelmann, R. E., Gittenberger-de Groot, A. C. (1998) Neural crest cell contribution to the developing circulatory system: implications for vascular morphology? Circ. Res. 82, Etchevers, H. C., Couly, G., Le Douarin, N. M. (2002) Morphogenesis of the branchial vascular sector. Trends Cardiovasc. Med. 12, Creazzo, T. L., Godt, R. E., Leatherbury, L., Conway, S. J., Kirby, M. L. (1998) Role of cardiac neural crest cells in cardiovascular development. Annu. Rev. Physiol. 60, DeRuiter, M. C., Poelmann, R. E., VanMunsteren, J. C., Mironov, V., Markwald, R. R., Gittenberger-de Groot, A. C. (1997) Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ. Res. 80, Yamashita, J., Itoh, H., Hirashima, M., Ogawa, M., Nishikawa, S., Yurugi, T., Naito, M., Nakao, K. (2000) Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408, Ruhrberg, C. (2003) Growing and shaping the vascular tree: multiple roles for VEGF. Bioessays 25, Hellstrom, M., Kalen, M., Lindahl, P., Abramsson, A., Betsholtz, C. (1999) Role of PDGF-B and PDGFR- in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126, Hirschi, K. K., Rohovsky, S. A., Beck, L. H., Smith, S. R., D Amore, P. A. (1999) Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-bb and heterotypic cell contact. Circ. Res. 84, Leveen, P., Pekny, M., Gebre-Medhin, S., Swolin, B., Larsson, E., Betsholtz, C. (1994) Mice deficient for PDGF-B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8, Soriano, P. (1994) Abnormal kidney development and hematological disorders in PDGF -receptor mutant mice. Genes Dev. 8, Lindahl, P., Johansson, B., Leveen, P., Betsholtz, C. (1997) Pericyte loss and microaneurysm formation inpdgf-b-deficient mice. Science 277, Tallquist, M. D., Klinghoffer, R. A., Heuchel, R., Mueting-Nelsen, P. F., Corrin, P. D., Heldin, C. H., Johnson, R. J., Soriano, P. (2000) Retention of PDGFR- function in mice in the absence of phosphatidylinositol 3 -kinase and phospholipase C signaling pathways. Genes Dev. 14, Tallquist, M., Kazlauskas, A. (2004) PDGF signaling in cells and mice. Cytokine Growth Factor Rev. 15, Jain, R. K. (2003) Molecular regulation of vessel maturation. Nat. Med. 9, Baluk, P., Hashizume, H., McDonald, D. M. (2005) Cellular abnormalities of blood vessels as targets in cancer. Curr. Opin. Genet. Dev. 15, Morikawa, S., Baluk, P., Kaidoh, T., Haskell, A., Jain, R. K., McDonald, D. M. (2002) Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am. J. Pathol. 160, Song, S., Ewald, A. J., Stallcup, W., Werb, Z., Bergers, G. (2005) PDGFR perivascular progenitor cells in tumors regulate pericyte differentiation and vascular survival. Nat. Cell Biol. 7, Reinmuth, N., Liu, W., Jung, Y. D., Ahmad, S. A., Shaheen, R. M., Fan, F., Bucana, C. D., McMahon, G., Gallick, G. E., Ellis, L. M. (2001) Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J. 15, Shaheen, R. M., Tseng, W. W., Davis, D. W., Liu, W., Reinmuth, N., Vellagas, R., Wieczorek, A. A., Ogura, Y., McConkey, D. J., Drazan, K. E., Bucana, C. D., McMahon, G., Ellis, L. M. (2001) Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms. Cancer Res. 61, Bergers, G., Song, S., Meyer-Morse, N., Bergsland, E., Hanahan, D. (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J. Clin. Invest. 111, Benjamin, L. E., Golijanin, D., Itin, A., Pode, D., Keshet, E. (1999) Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103, Pietras, K., Hanahan, D. (2005) A multitargeted, metronomic, and maximum-tolerated dose chemo-switch regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer. J. Clin. Oncol. 23, Xian, X., Hakansson, J., Stahlberg, A., Lindblom, P., Betsholtz, C., Gerhardt, H., Semb, H. (2006) Pericytes limit tumor cell metastasis. J. Clin. Invest. 116, Grunewald, M., Avraham, I., Dor, Y., Bachar-Lustig, E., Itin, A., Yung, S., Chimenti, S., Landsman, L., Abramovitch, R., Keshet, E. (2006) VEGFinduced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124, De Palma, M., Venneri, M. A., Galli, R., Sergi, L. S., Politi, L. S., Sampaolesi, M., Naldini, L. (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8, Jin, D. K., Shido, K., Kopp, H. G., Petit, I., Shmelkov, S. V., Young, L. M., Hooper, A. T., Amano, H., Avecilla, S. T., Heissig, B., Hattori, K., Zhang, F., Hicklin, D. J., Wu, Y., Zhu, Z., Dunn, A., Salari, H., Werb, Z., Hackett, N. R., Crystal, R. G., Lyden, D., Rafii, S. (2006) Cytokinemediated deployment of SDF-1 induces revascularization through recruitment of CXCR4( ) hemangiocytes. Nat. Med. 12, Aghi, M., Chiocca, E. A. (2005) Contribution of bone marrow-derived cells to blood vessels in ischemic tissues and tumors. Mol. Ther. 12, Spring, H., Schuler, T., Arnold, B., Hammerling, G. J., Ganss, R. (2005) Chemokines direct endothelial progenitors into tumor neovessels. Proc. Natl. Acad. Sci. USA 102, Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D., Moore, M. A., Werb, Z., Rafii, S. (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109, Kopp, H. G., Ramos, C. A., Rafii, S. (2006) Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr. Opin. Hematol. 13, Journal of Leukocyte Biology Volume 80, October
5 36. Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., Gurtner, G. C. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10, De Falco, E., Porcelli, D., Torella, A. R., Straino, S., Iachininoto, M. G., Orlandi, A., Truffa, S., Biglioli, P., Napolitano, M., Capogrossi, M. C., Pesce, M. (2004) SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104, Rajantie, I., Ilmonen, M., Alminaite, A., Ozerdem, U., Alitalo, K., Salven, P. (2004) Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 104, Jodele, S., Chantrain, C. F., Blavier, L., Lutzko, C., Crooks, G. M., Shimada, H., Coussens, L. M., Declerck, Y. A. (2005) The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9-dependent. Cancer Res. 65, Kokovay, E., Li, L., Cunningham, L. A. (2006) Angiogenic recruitment of pericytes from bone marrow after stroke. J. Cereb. Blood Flow Metab. 26, Ozerdem, U., Alitalo, K., Salven, P., Li, A. (2005) Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis. Invest. Ophthalmol. Vis. Sci. 46, De Palma, M., Venneri, M. A., Roca, C., Naldini, L. (2003) Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat. Med. 9, Direkze, N. C., Hodivala-Dilke, K., Jeffery, R., Hunt, T., Poulsom, R., Oukrif, D., Alison, M. R., Wright, N. A. (2004) Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res. 64, Lamagna and Bergers Bone marrow and pericyte progenitors 5
Signaling Vascular Morphogenesis and Maintenance
Signaling Vascular Morphogenesis and Maintenance Douglas Hanahan Science 277: 48-50, in Perspectives (1997) Blood vessels are constructed by two processes: vasculogenesis, whereby a primitive vascular
More informationThe Process of Angiogenesis & Inhibition of Angiogenesis and/or Lymphangiogenesis
The Process of Angiogenesis & Inhibition of Angiogenesis and/or Lymphangiogenesis Nam Deuk Kim, Ph.D. Pusan National University Contents Part 1. The process of angiogenesis Part 2. The role of angiopoietins
More informationHeterotypy and Angiogenesis
Heterotypy and Angiogenesis Tumors are perpetual wounds 1. Normally stroma and epithelia converse at a distance. 2. Juxtaposition of stroma and epithelia is indicative of tissue damage. 4. Activate strategies
More informationMechanisms of Resistance to Antiangiogenic. Martin J. Edelman, MD University of Maryland Greenebaum Cancer Center Dresden, 2012
Mechanisms of Resistance to Antiangiogenic Agents Martin J. Edelman, MD University of Maryland Greenebaum Cancer Center Dresden, 2012 Angiogenesis: A fundamental attribute of cancer Premise of Anti-angiogenic
More informationChapter 6. Villous Growth
Core Curriculum in Perinatal Pathology Chapter 6 Villous Growth Overview of vasculogenesis and angiogenesis Vasculogenesis Extraembryonic Vasculogenesis Angiogenesis Branching angiogenesis Sprouting angiogenesis
More informationThe Angiopoietin Axis in Cancer
Ang2 Ang1 The Angiopoietin Axis in Cancer Tie2 An Overview: The Angiopoietin Axis Plays an Essential Role in the Regulation of Tumor Angiogenesis Growth of a tumor beyond a limiting size is dependent upon
More informationAngiogenesis as a therapeutic target
Angiogenesis as a therapeutic target Lecture Experimentelle Krebsforschung SS 07 Prof. Gerhard Christofori Institute of Biochemistry and Genetics Department of Clinical-Biological Sciences University of
More informationInflammatory Cells and Metastasis
Inflammatory Cells and Metastasis Experimentelle Krebsforschung SS 07 Gerhard Christofori Institute of Biochemistry and Genetics Department of Clinical-Biological Sciences Center of Biomedicine University
More informationAngiogenesis in Human Development. Vascular Development
Angiogenesis in Human Development Jan Kitajewski ICRC 217B, ph 851-4688, email: jkk9 BACKGROUND READING: Vascular Development Signaling Vascular Morphogenesis and Maintenance Douglas Hanahan. Science 277:
More informationTissue repair. (3&4 of 4)
Tissue repair (3&4 of 4) What will we discuss today: Regeneration in tissue repair Scar formation Cutaneous wound healing Pathologic aspects of repair Regeneration in tissue repair Labile tissues rapid
More informationTissue renewal and Repair. Nisamanee Charoenchon, PhD Department of Pathobiology, Faculty of Science
Tissue renewal and Repair Nisamanee Charoenchon, PhD Email: nisamanee.cha@mahidol.ac.th Department of Pathobiology, Faculty of Science Topic Objectives 1. Describe processes of tissue repair, regeneration
More informationProcessing of VEGF-C and -D by the Proprotein Convertases: Importance in Angiogenesis, Lymphangiogenesis, and Tumorigenesis
Processing of VEGF-C and -D by the Proprotein Convertases: Importance in Angiogenesis, Lymphangiogenesis, and Tumorigenesis ii Colloquium Digital Library of Life Sciences This e-book is an original work
More informationCritical Reviews in Oncology/Hematology 69 (2009) Berber D. Roorda, Arja ter Elst, Willem A. Kamps, Eveline S.J.M.
Critical Reviews in Oncology/Hematology 69 (2009) 187 198 Bone marrow-derived cells and tumor growth: Contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal
More informationAngiogenesis in urothelial tumors of the upper urinary tract
Romanian Journal of Morphology and Embryology 2005, 46(4):263 268 Angiogenesis in urothelial tumors of the upper urinary tract FLAVIA BADERCA 1), RODICA LIGHEZAN 1), ALIS DEMA 2), AURORA ALEXA 1), M. RAICA
More information1. The metastatic cascade. 3. Pathologic features of metastasis. 4. Therapeutic ramifications. Which malignant cells will metastasize?
1. The metastatic cascade 3. Pathologic features of metastasis 4. Therapeutic ramifications Sir James Paget (1814-1899) British Surgeon/ Pathologist Paget s disease of Paget s disease of the nipple (intraductal
More information1.The metastatic cascade. 2.Pathologic features of metastasis. 3.Therapeutic ramifications
Metastasis 1.The metastatic cascade 2.Pathologic features of metastasis 3.Therapeutic ramifications Sir James Paget (1814-1899) British Surgeon/ Pathologist Paget s disease of bone Paget s disease of the
More informationUNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA PhD SCHOOL. PhD THESIS
UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA PhD SCHOOL PhD THESIS THE IMPORTANCE OF TUMOR ANGIOGENESIS IN CEREBRAL TUMOR DIAGNOSIS AND THERAPY ABSTRACT PhD COORDINATOR: Prof. univ. dr. DRICU Anica PhD
More informationRIP-Tag2 mouse model as a Paradigm for Target. Search in NETs
RIP-Tag2 mouse model as a Paradigm for Target Search in NETs Oriol Casanovas, Ph.D. Tumor Angiogenesis Group INSTITUT CATALÀ d ONCOLOGIA IDIBELL Barcelona (SPAIN) Therapeutic Targeting of the Tumor Stroma
More informationNeoplasia 18 lecture 8. Dr Heyam Awad MD, FRCPath
Neoplasia 18 lecture 8 Dr Heyam Awad MD, FRCPath ILOS 1. understand the angiogenic switch in tumors and factors that stimulate and inhibit angiogenesis. 2. list the steps important for tumor metastasis
More informationMeeting Report. From December 8 to 11, 2012 at Atlanta, GA, U.S.A
Meeting Report Affiliation Department of Transfusion Medicine and Cell Therapy Name Hisayuki Yao Name of the meeting Period and venue Type of your presentation Title of your presentation The 54 th Annual
More informationTumor Microenvironment in the Brain
Cancers 2012, 4, 218-243; doi:10.3390/cancers4010218 Review OPEN ACCESS cancers ISSN 2072-6694 www.mdpi.com/journal/cancers Tumor Microenvironment in the Brain Mihaela Lorger Leeds Institute of Molecular
More informationREVIEW Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells
(2002) 9, 648 652 2002 Nature Publishing Group All rights reserved 0969-7128/02 $25.00 www.nature.com/gt REVIEW Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells KK Hirschi 1
More informationSupplementary Note
Supplementary Note 1. Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-9 (1996). 2. Ferrara, N. et al. Heterozygous embryonic
More informationRole of Inflammatory and Progenitor Cells in Pulmonary Vascular Remodeling: Potential Role for Targeted Therapies. Traditional Hypothesis Stress
3/1/212 Role of Inflammatory and Progenitor Cells in Pulmonary Vascular Remodeling: Potential Role for Targeted Therapies K.R. Stenmark University of Colorado Denver, CO 845 Prominent Fibroproliferative
More informationRole of Inflammation in Pulmonary Hypertension
Role of Inflammation in Pulmonary Hypertension K. R. Stenmark University of Colorado Denver, USA Prominent Fibroproliferative Changes are Observed in the Lung Vasculature of Infants With Pulmonary Arterial
More informationProfessor Harvey White. Interventional Cardiologist Auckland
Professor Harvey White Interventional Cardiologist Auckland Stem cells and the heart Harvey White Director of Coronary Care Unit and Cardiovascular Research Unit Green Lane Cardiovascular Service Auckland
More informationRole of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse
Development 126, 3047-3055 (1999) Printed in Great Britain The Company of Biologists Limited 1999 DEV4135 3047 Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during
More informationThe Role of Microenvironment in the Control of Tumor Angiogenesis
The Role of Microenvironment in the Control of Tumor Angiogenesis Domenico Ribatti The Role of Microenvironment in the Control of Tumor Angiogenesis Domenico Ribatti Department of Basic Medical Sciences,
More information!!! Oncology for Scientists (RPN 530) Metastasis and Angiogenesis Chapter 13 and 14 Oct. 28 th 2014
Oncology for Scientists (RPN 530) Metastasis and Angiogenesis Chapter 13 and 14 Oct. 28 th 2014 Department of Cancer Genetics Masashi Muramatsu, Ph.D. About Exam First, think and understand the concepts.
More informationParacrine Mechanisms in Adult Stem Cell Signaling and Therapy
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy Massimiliano Gnecchi, Zhiping Zhang, Aiguo Ni, Victor J. Dzau Circulation Research 2008 Nov 21;103(11):1204-19 Introduction(1) After AMI all
More informationBone Marrow Progenitor Cells and Vascular Endothelium: Studies on the In Vivo Differentiation Capacity and the Role of Bmx Tyrosine Kinase
Bone Marrow Progenitor Cells and Vascular Endothelium: Studies on the In Vivo Differentiation Capacity and the Role of Bmx Tyrosine Kinase Iiro Rajantie Molecular/Cancer Biology Laboratory Haartman Institute
More informationrenoprotection therapy goals 208, 209
Subject Index Aldosterone, plasminogen activator inhibitor-1 induction 163, 164, 168 Aminopeptidases angiotensin II processing 64 66, 214 diabetic expression 214, 215 Angiotensin I intrarenal compartmentalization
More informationComputational Systems Biology: Biology X
Bud Mishra Room 1002, 715 Broadway, Courant Institute, NYU, New York, USA L#5:(October-18-2010) Cancer and Signals Outline 1 2 Outline 1 2 Cancer is a disease of malfunctioning cells. Cell Lineage: Adult
More informationMechanisms of Gene Regulation and Signal! Transduction in Hypoxia!
Mechanisms of Gene Regulation and Signal! Transduction in Hypoxia! Lorenz Poellinger! Dept. of Cell and Molecular Biology! Karolinska Institutet, Stockholm, Sweden! Normoxia - O 2 availability is in balance
More informationHeart 3: Organogenesis, CHD, prenatal circulation
Heart 3: Organogenesis, CHD, prenatal circulation Heart development Development of vasculature Pathogenesis of CHD Prenatal circulation and its remodeling after birth David Sedmera Charles University First
More informationBL-8040: BEST-IN-CLASS CXCR4 ANTAGONIST FOR TREATMENT OF ONCOLOGICAL MALIGNANCIES. Overview and Mechanism of Action Dr.
BL-8040: BEST-IN-CLASS CXCR4 ANTAGONIST FOR TREATMENT OF ONCOLOGICAL MALIGNANCIES Overview and Mechanism of Action Dr. Leah Klapper, CSO 88 BL-8040: Novel CXCR4 Antagonist For Hematological Cancers Indications:
More informationTumor Associated Macrophages as a Novel Target for Cancer Therapy
Tumor mass Tumor Associated Macrophage Tumor Associated Macrophages as a Novel Target for Cancer Therapy This booklet contains forward-looking statements that are based on Amgen s current expectations
More informationOncolytic Virotherapy: Targeting Cancer Stem Cells
Oncolytic Virotherapy: Targeting Cancer Stem Cells Cancer Stem Cells (CSCs) or Cancer Initiating Cells (CICs) A consensus of five defining criteria has been established to affirm the existence of CICs:
More informationHealing and Repair. Dr. Nabila Hamdi MD, PhD
Healing and Repair Dr. Nabila Hamdi MD, PhD 1 ILOs Know the classification of human cells according to their ability for proliferation. Understand the mechanism of cellular regeneration. Identify the types
More informationVEGFR-3 in Angiogenesis and Lymphangiogenesis
VEGFR-3 in Angiogenesis and Lymphangiogenesis Lotta Jussila Molecular/Cancer Biology Laboratory Haartman Institute and Helsinki University Central Hospital Biomedicum Helsinki University of Helsinki Finland
More informationCD34+ Cells: A Comparison of Stem and Progenitor Cells in Cord Blood, Peripheral Blood, and the Bone Marrow
White Paper September 2016 CD34+ Cells: A Comparison of Stem and Progenitor Cells in Cord Blood, Peripheral Blood, and the Bone Marrow Lily C. Trajman, PhD Introduction: Hematopoietic Stem Cells (HSCs)
More informationCD34 + VEGFR-3 + progenitor cells have a potential to differentiate towards lymphatic endothelial cells
CD34 + VEGFR-3 + progenitor cells have a potential to differentiate towards lymphatic endothelial cells Tan YZ et al. J Cell Mol Med. (2014 Mar;18(3):422-33) Denise Traxler-Weidenauer April 2014 Introduction
More informationMesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future
Mesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future Cell Therapy 2014 Las Vegas, NV, USA Sulaiman Al-Hashmi, PhD Sultan Qaboos University Oman What are MSCs? Stem
More informationPathology of Coronary Artery Disease
Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology
More informationCancer as a disease of development; Developmental therapies: Anti- Angiogenesis; Stem cells and tissue regeneration.
Cancer as a disease of development; Developmental therapies: Anti- Angiogenesis; Stem cells and tissue regeneration Mitesh Shrestha What is Cancer? Unrestricted cell growth: tumor cell population 1x10^9
More informationBenefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors See the related Commentary beginning on page 1277. Gabriele Bergers, 1,2 Steven Song, 1,2 Nicole
More informationPericytes limit tumor cell metastasis
Research article Pericytes limit tumor cell metastasis Xiaojie Xian, 1 Joakim Håkansson, 2 Anders Ståhlberg, 1 Per Lindblom, 3 Christer Betsholtz, 4 Holger Gerhardt, 3 and Henrik Semb 1 1 Stem Cell Center,
More informationAnalysis on the mechanism of reduced nephron number and the pathological progression of chronic renal failure in Astrin deficient rats
Analysis on the mechanism of reduced nephron number and the pathological progression of chronic renal failure in Astrin deficient rats Summary of Doctoral Thesis Hidenori Yasuda Graduate School of Veterinary
More informationCitation for published version (APA): Velde, S. V. D. (2006). Stem cell-mediated regeneration of the infarcted heart: inflammation rules? s.n.
University of Groningen Stem cell-mediated regeneration of the infarcted heart Velde, Susanne van der IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to
More informationPhD THESIS Epigenetic mechanisms involved in stem cell differentiation
Romanian Academy Institute of Cellular Biology and Pathology "Nicolae Simionescu" PhD THESIS Epigenetic mechanisms involved in stem cell differentiation Coordinator: Acad. Maya Simionescu PhD Student:
More informationNintedanib in Oncology Backgrounder
For media outside the US, UK and Canada only Nintedanib in Oncology Backgrounder 1. What is nintedanib? 2. How does nintedanib work? 3. Data overview 4. Additional clinical data 5. Nintedanib approval
More informationAnimal Tissue Culture SQG 3242 Biology of Cultured Cells. Dr. Siti Pauliena Mohd Bohari
Animal Tissue Culture SQG 3242 Biology of Cultured Cells Dr. Siti Pauliena Mohd Bohari The Culture Environment Changes of Cell s microenvironment needed that favor the spreading, migration, and proliferation
More informationRecombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells
Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells See the related Commentary beginning on page 1615. Akiyoshi Uemura, 1,2 Minetaro
More informationReview. Leukocyte Migration in the Vascular Wall Molecular Mechanisms of Endothelial Cell Migration Kathy K. Griendling, Editor
Review This Review is part of a thematic series on Migration of Vascular Cells, which includes the following articles: Mechanisms of Vascular Smooth Muscle Cell Migration Endothelial Cell Migration During
More informationReview. Endothelial Extracellular Matrix: Biosynthesis, Remodeling, and Functions During Vascular Morphogenesis and Neovessel Stabilization
Review This Review is part of a thematic series on Vascular Cell Diversity, which includes the following articles: Heart Valve Development: Endothelial Cell Signaling and Differentiation Molecular Determinants
More informationCancer Biology Course. Invasion and Metastasis
Cancer Biology Course Invasion and Metastasis 2016 Lu-Hai Wang NHRI Cancer metastasis Major problem: main reason for killing cancer patients, without it cancer can be cured or controlled. Challenging questions:
More informationCardiac Myocytes are Recruited by Bone Marrow-Derived Cells in Intact Murine Heart
Kobe J. Med. Sci., Vol. 48, No. 6, pp. 161-166, 2002 Cardiac Myocytes are Recruited by Bone Marrow-Derived Cells in Intact Murine Heart SEIMI SATOMI-KOBAYASHI 1, SEINOSUKE KAWASHIMA 1*, TSUYOSHI SAKODA
More informationJOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T. preclinical development for cancer indications 6 and one, the vascular endothelial
NUMBER FEBRUARY VOLUME 23 d 5 d 10 05 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T A Multitargeted, Metronomic, and Maximum-Tolerated Dose Chemo-Switch Regimen is Antiangiogenic, Producing
More informationReviews. This Review is part of a thematic series on Cellular Therapy, which includes the following articles:
Reviews This Review is part of a thematic series on Cellular Therapy, which includes the following articles: The Stem Cell Movement Genetic Enhancement of Stem Cell Engraftment, Survival, and Efficacy
More informationVascular Basement Membrane Components in Angiogenesis An Act of Balance
Directions in Science TheScientificWorldJOURNAL (2008) 8, 1246 1249 ISSN 1537-744X; DOI 10.1100/tsw.2008.155 Vascular Basement Membrane Components in Angiogenesis An Act of Balance Lars Jakobsson 1, *
More informationDECLARATION OF CONFLICT OF INTEREST. No disclosures
DECLARATION OF CONFLICT OF INTEREST No disclosures micrornas: Role in progression of atherosclerosis Christian Weber Institute for Cardiovascular Prevention (IPEK) Ludwig-Maximilians-University Munich
More informationMicrovascular rarefaction, angiogenesis and hypertension
Microvascular rarefaction, angiogenesis and hypertension Bernard I. Lévy PARRC Inserm U970 Institut des Vaisseaux et du Sang Hôpital Lariboisière, Paris. Microcirculation ± 90% of the systemic resistance
More informationReview of relationship between vascular endothelial growth factor family & receptors and tumor angiogenesis
16 1 2004 2 hinese Bulletin of Life Sciences Vol. 16, No. 1 Feb., 2004 1004-0374 (2004) 01-0019-05 1 201203 2 200025 (vascular endothelial growth factor, ) (vascular permeability factor, VPF), -A -B -
More informationReview Article Angiogenesis in Spontaneous Tumors and Implications for Comparative Tumor Biology
e Scientific World Journal, Article ID 919570, 16 pages http://dx.doi.org/10.1155/2014/919570 Review Article Angiogenesis in Spontaneous Tumors and Implications for Comparative Tumor Biology C. Benazzi,
More informationBONE MARROW DERIVED CELLS IN ANGIOGENESIS AND CANCER. Susanna Lauttia
Helsinki University Biomedical Dissertations No. 197 BONE MARROW DERIVED CELLS IN ANGIOGENESIS AND CANCER Susanna Lauttia Research Programs Unit, Translational Cancer Biology Faculty of Medicine University
More informationHealing & Repair. Tissue Regeneration
Healing & Repair Dr. Srikumar Chakravarthi Repair & Healing: Are they same? Repair :Regeneration of injured cells by cells of same type, as with regeneration of skin/oral mucosa (requires basement membrane)
More informationAngiogenesis and Metastasis
Angiogenesis and Metastasis 10/31/2017 Tariq Bhat (Ph.D.) Definition of Angiogenesis: Formation of new blood vessels/capillaries from the pre-existing vessels/capillaries Involves - sprouting - splitting
More informationEditor Journal of Allergy and Therapy
Editor Journal of Allergy and Therapy Biography Prof. Domenico Ribatti was awarded his MD degree on October 1981 with full marks. His present position is of a full-time professor of Human Anatomy at the
More informationLymphoid architecture & Leukocyte recirculation. Thursday Jan 26th, 2017
Lymphoid architecture & Leukocyte recirculation Thursday Jan 26th, 2017 Topics The life of immune cells Where are they born? Where are they educated? Where do they function? How do they get there? The
More informationMr S. is a 62-year-old restaurant owner who has had
Brief Review: From Bench to Bedside Endothelial Progenitor Cells New Hope for a Broken Heart Paul E. Szmitko, BSc; Paul W.M. Fedak, MD; Richard D. Weisel, MD; Duncan J. Stewart, MD; Michael J.B. Kutryk,
More informationSeeds and soil theory by Stephen Paget at the end of the XIX century.
Seeds and soil theory by Stephen Paget at the end of the XIX century. In The Distribution Of Secondary Growths In Cancer Of The Breast Paget presents and analyzes 735 fatal cases of breast cancer, complete
More informationChapter 2 (pages 22 33): Cells and Tissues of the Immune System. Prepared by Kristen Dazy, MD, Scripps Clinic Medical Group
Allergy and Immunology Review Corner: Cellular and Molecular Immunology, 8th Edition By Abul K. Abbas, MBBS; Andrew H. H. Lichtman, MD, PhD; and Shiv Pillai, MBBS, PhD. Chapter 2 (pages 22 33): Cells and
More informationAngiostasis and Angiogenesis Regulated by Angiopoietin1-Tie2 Receptor System
Japan-Mexico Workshop on Pharmacology and Nanobiology Feb. 25, 2009; Universidad Nacional Autönoma de Mëxico, Mexico City Angiostasis and Angiogenesis Regulated by Angiopoietin1-Tie2 Receptor System Shigetomo
More informationulcer healing role 118 Bicarbonate, prostaglandins in duodenal cytoprotection 235, 236
Subject Index Actin cellular forms 48, 49 epidermal growth factor, cytoskeletal change induction in mucosal repair 22, 23 wound repair 64, 65 polyamine effects on cytoskeleton 49 51 S-Adenosylmethionine
More informationHematopoiesis. - Process of generation of mature blood cells. - Daily turnover of blood cells (70 kg human)
Hematopoiesis - Process of generation of mature blood cells - Daily turnover of blood cells (70 kg human) 1,000,000,000,000 total cells 200,000,000,000 red blood cells 70,000,000,000 neutrophils Hematopoiesis
More informationDECLARATION OF CONFLICT OF INTEREST. No conflicts of interest
DECLARATION OF CONFLICT OF INTEREST No conflicts of interest University Heart Centre Tübingen Angiogenic actions of platelets Meinrad Gawaz, MD, FESC Tübingen, Germany ESC 2011 Paris GPIb GPIb GPVI TxA2
More informationnumber Done by Corrected by Doctor Maha Shomaf
number 21 Done by Ahmad Rawajbeh Corrected by Omar Sami Doctor Maha Shomaf Ability to Invade and Metastasize The metastatic cascade can be subdivided into two phases: 1-invasion of ECM and vascular dissemination:
More informationBone marrow derived cells in the tumour microenvironment contain cells with primitive haematopoietic phenotype
J. Cell. Mol. Med. Vol 14, No 7, 2010 pp. 1946-1952 Bone marrow derived cells in the tumour microenvironment contain cells with primitive haematopoietic phenotype Erika Deak a, b, Stephan Göttig a, Brigitte
More informationIncreasing evidence indicates that bone marrow-derived
Downloaded from http://stroke.ahajournals.org/ by guest on July 21, 2018 Bone Marrow-Derived Cells Contribute to Vascular Endothelial Growth Factor Induced Angiogenesis in the Adult Mouse Brain by Supplying
More informationR J M E Romanian Journal of Morphology & Embryology
Rom J Morphol Embryol 2012, 53(3 Suppl):749 753 ORIGINAL PAPER R J M E Romanian Journal of Morphology & Embryology http://www.rjme.ro/ The characterization of PDGFR-alpha and PDGFR-beta expression in malignant
More informationConstruction of Nephron by Fusion of Adult Glomeruli to Ureteric Buds with Type V Collagen. Yusuke Murasawa, Pi-chao Wang
Construction of Nephron by Fusion of Adult Glomeruli to Ureteric Buds with Type V Collagen Yusuke Murasawa, Pi-chao Wang Abstract Although tissue engineering of artificial organs such as skin or cartilage
More informationCytokines, adhesion molecules and apoptosis markers. A comprehensive product line for human and veterinary ELISAs
Cytokines, adhesion molecules and apoptosis markers A comprehensive product line for human and veterinary ELISAs IBL International s cytokine product line... is extremely comprehensive. The assays are
More informationRole of BAFF in B cell Biology and Autoimmunity
Role of BAFF in B cell Biology and Autoimmunity B cell development in health and disease: B-lymphocytes or B cells, and the antibodies they produce, are crucial mediators of humoral immunity, providing
More informationHEM- AND LYMPH- ANGIOGENESIS IN CANCER METASTASIS
From THE DEPARTMENT OF MICROBIOLOGY, TUMOR AND CELL BIOLOGY Karolinska Institutet, Stockholm, Sweden HEM- AND LYMPH- ANGIOGENESIS IN CANCER METASTASIS Hong Ji Stockholm 2013 All previously published papers
More informationDisorders of Cell Growth & Neoplasia. Lecture 4 Molecular basis of cancer
General Pathology VPM 152 Disorders of Cell Growth & Neoplasia Lecture 4 Molecular basis of cancer Enrique Aburto Apr 2010 Skin tumor in a 10-year-old Rottweiler. Considering the external appearance and
More informationThe Role of Angiopoietin-2 in Signaling Through the Endothelial. Receptor Tyrosine Kinase Tie1
The Role of Angiopoietin-2 in Signaling Through the Endothelial Receptor Tyrosine Kinase Tie1 by Balint Istvan Otvos Department of Pathology Duke University Date: Approved: Christopher D. Kontos, Supervisor
More informationRole of VEGF in vasculogenesis and angiogenesis
Role of VEGF in vasculogenesis and angiogenesis lecture II 14th March 2011 Angiogenesis and VEGF history 1787 Dr John Hunter first uses the term 'angiogenesis' to describe blood vessels growth 1983 Vascular
More informationStem cells and Cancer. John Glod. December 2, 2009
Stem cells and Cancer John Glod Lehigh University Lehigh University December 2, 2009 The Tumor Microenvironment Littlepage et al Cancer Cell 2005 Cancer Stem Cells A small group of cells within the larger
More informationQuestion 1. Kupffer cells, microglial cells and osteoclasts are all examples of what type of immune system cell?
Abbas Chapter 2: Sarah Spriet February 8, 2015 Question 1. Kupffer cells, microglial cells and osteoclasts are all examples of what type of immune system cell? a. Dendritic cells b. Macrophages c. Monocytes
More informationMOLECULAR ONCOLOGY 5 (2011) 137e149. available at
available at www.sciencedirect.com www.elsevier.com/locate/molonc Review Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: One step forward for overcoming anti-angiogenic
More informationPATHOBIOLOGY OF NEOPLASIA
PATHOBIOLOGY OF NEOPLASIA Department of Pathology Gadjah Mada University School of Medicine dr. Harijadi Blok Biomedis, 6 Maret 2009 [12] 3/17/2009 1 The pathobiology of neoplasia Normal cells Malignant
More informationHaematopoietic stem cells
Haematopoietic stem cells Neil P. Rodrigues, DPhil NIH Centre for Biomedical Research Excellence in Stem Cell Biology Boston University School of Medicine neil.rodrigues@imm.ox.ac.uk Haematopoiesis: An
More informationTHE ROLE OF anti-vegf IN DIABETIC RETINOPATHY AND AGE RELATED MACULAR DEGENERATION
THE ROLE OF anti-vegf IN DIABETIC RETINOPATHY AND AGE RELATED MACULAR DEGENERATION MOESTIDJAB DEPARTMENT OF OPHTHALMOLOGY SCHOOL OF MEDICINE AIRLANGGA UNIVERSITY DR SOETOMO HOSPITAL SURABAYA INTRODUCTION
More informationBiology of perivascular progenitor cells
Biology of perivascular progenitor cells Paolo Madeddu, MD FAHA Chair Experimental Cardiovascular Medicine Head of Regenerative Medicine Section madeddu@yahoo.com Monday 13 th June 2011 CBCS Summer School
More informationRAS Genes. The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes.
۱ RAS Genes The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes. Oncogenic ras genes in human cells include H ras, N ras,
More informationJournal Club Semmler Lorenz
Beer et al. 2015 - Analysis of the Secretome of Apoptotic Peripheral Blood Mononuclear Cells: Impact of Released Proteins and Exosomes for Tissue Regeneration Journal Club 13.11.2017 1 Introduction to
More informationStem cells and the vasculature
F o c u s o n Va s c u l a r D i s e a s e r e v i e w Stem and the vasculature Victoria L Bautch 1 3 Unraveling the contribution of stem and progenitor to blood vessel formation and, reciprocally, the
More informationCrosstalk between Adiponectin and IGF-IR in breast cancer. Prof. Young Jin Suh Department of Surgery The Catholic University of Korea
Crosstalk between Adiponectin and IGF-IR in breast cancer Prof. Young Jin Suh Department of Surgery The Catholic University of Korea Obesity Chronic, multifactorial disorder Hypertrophy and hyperplasia
More information